Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Frailty 5 Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Urogenital Neoplasms 1 Solid Neoplasm 1 Sarcopenia 1 Sarcoma 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Hepatic Malignancies 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Health Education 1 Head and Neck Neoplasms 1 Communication 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 59 Cisplatin 45 Cetuximab 29 Radiotherapy 26 Carboplatin 24 Docetaxel 17 Paclitaxel 16 Nivolumab 16 Surveys and Questionnaires 15 Radiotherapy, Intensity-Modulated 13 Fluorouracil 12 Drug Therapy 12 Blood Specimen Collection 11 Standard of Care 8 tislelizumab 7 cemiplimab 6 atezolizumab 6 Radiation 6 Chemoradiotherapy 6 toripalimab 5 Cyclophosphamide 5 130-nm albumin-bound paclitaxel 5 nimotuzumab 4 fludarabine 4 durvalumab 4 dostarlimab 4 Surgical Procedures, Operative 4 Afatinib 4 palbociclib 3 niraparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Geriatric Assessment × 1 year × Clear all

NCT06638216 2025-08-28

PRE-KOVERI

Charite University, Berlin, Germany

Phase NA Completed

Frailty, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡